LLY — Eli Lilly and Co Cashflow Statement
0.000.00%
Last trade - 00:00
- $690.55bn
- $712.94bn
- $34.12bn
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 8,318 | 6,194 | 5,582 | 6,245 | 5,240 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -3,090 | -136 | 1,956 | 2,004 | 2,868 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1,687 | -747 | -1,023 | -0.8 | -3,055 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Cash from Operating Activities | 4,837 | 6,500 | 7,261 | 7,586 | 4,240 |
Capital Expenditures | -1,354 | -2,029 | -1,873 | -2,985 | -7,392 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -6,729 | -230 | -889 | -778 | 239 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -8,083 | -2,259 | -2,762 | -3,763 | -7,153 |
Financing Cash Flow Items | -200 | -242 | -296 | -309 | -335 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -2,325 | -3,137 | -4,131 | -5,407 | 3,496 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -5,661 | 1,320 | 161 | -1,752 | 752 |